Amy W Schulman is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 8,436 shares of ALNY, which is worth approximately $2.1 Million. The most recent transaction as insider was on Jun 25, 2024, when has been sold 8,500 shares (Common Stock) at a price of $240.0 per share, resulting in proceeds of $2,040,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.44K
0% 3M change
6102.94% 12M change
Total Value Held $2.1 Million

AMY W SCHULMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2024
SELL
Open market or private sale
$2,040,000 $240.0 p/Share
8,500 Reduced 50.19%
8,436 Common Stock
Jun 25 2024
BUY
Exercise of conversion of derivative security
$1,115,285 $131.21 p/Share
8,500 Added 33.42%
16,936 Common Stock
May 29 2024
SELL
Open market or private sale
$3,232,649 $148.97 p/Share
21,700 Reduced 72.01%
8,436 Common Stock
May 29 2024
BUY
Exercise of conversion of derivative security
$2,004,900 $66.83 p/Share
30,000 Added 49.89%
30,136 Common Stock
Feb 23 2023
BUY
Exercise of conversion of derivative security
-
136 Added 50.0%
136 Common Stock

Also insider at

SQZ
SQZ Biotechnologies Co Healthcare
HCIIW
Hudson Executive Investment Corp. II ETFs
GUTS
Fractyl Health, Inc.
AWS

Amy W Schulman

Director
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Track Activities on ALNY